$580 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 63 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 35.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TDOC | Buy | TELADOC HEALTH | $35,588,000 | +4.4% | 525,511 | +2.4% | 6.14% | +50.7% |
| FOLD | Buy | AMICUS THERAPEUTICS | $27,604,000 | -33.5% | 3,441,922 | +3.5% | 4.76% | -4.0% |
| TNDM | Buy | TANDEM DIABETES CARE | $25,527,000 | +23.7% | 432,815 | +35.3% | 4.40% | +78.4% |
| APLS | Sell | APELLIS PHARMACEUTIC | $24,017,000 | -36.4% | 996,983 | -33.1% | 4.14% | -8.2% |
| WMGI | Buy | WRIGHT MED GROUP N V | $21,948,000 | +44.0% | 1,063,872 | +108.1% | 3.79% | +107.7% |
| AERI | Buy | AERIE PHARMACEUTIC | $20,979,000 | -25.7% | 1,091,534 | +14.2% | 3.62% | +7.1% |
| SWAV | Sell | SHOCKWAVE MEDICAL | $17,163,000 | -64.6% | 573,434 | -32.5% | 2.96% | -49.0% |
| INSP | Buy | INSPIRE MED SYS INC | $16,054,000 | +118.9% | 263,100 | +117.6% | 2.77% | +215.8% |
| GILD | Sell | GILEAD SCIENCES INC | $15,651,000 | -41.8% | 246,940 | -38.0% | 2.70% | -16.0% |
| ALNY | Sell | ALNYLAM PHARMACUETCL | $14,825,000 | -49.3% | 184,341 | -54.2% | 2.56% | -26.8% |
| PTLA | Sell | PORTOLA PHARMACEUTIC | $14,657,000 | -25.1% | 546,489 | -24.3% | 2.53% | +8.0% |
| BMY | Buy | BRISTOL MYERS SQUIBB | $14,229,000 | +46.1% | 280,597 | +30.7% | 2.46% | +110.9% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES | $13,914,000 | +103.2% | 187,750 | +116.8% | 2.40% | +193.0% |
| NVS | Sell | NOVARTIS AGsponsored adr | $12,848,000 | -23.0% | 147,846 | -19.1% | 2.22% | +11.2% |
| PTCT | Sell | PTC THERAPEUTICS I | $12,758,000 | -37.1% | 377,238 | -16.3% | 2.20% | -9.2% |
| FGEN | Buy | FIBROGEN INC | $12,331,000 | -9.8% | 333,460 | +10.2% | 2.13% | +30.1% |
| IMMU | Buy | IMMUNOMEDICS INC | $12,064,000 | +107.6% | 909,822 | +117.2% | 2.08% | +199.4% |
| VCRA | Buy | VOCERA COMMUNICATI | $11,801,000 | -3.1% | 478,728 | +25.5% | 2.04% | +39.7% |
| GBT | Buy | GLOBAL BLOOD THERA | $11,695,000 | -1.7% | 241,040 | +6.5% | 2.02% | +41.8% |
| EVH | Buy | EVOLENT HEALTH INC | $11,402,000 | +5.6% | 1,585,752 | +16.7% | 1.97% | +52.4% |
| ATRC | Buy | ATRICURE INC | $11,160,000 | -3.4% | 447,455 | +15.6% | 1.92% | +39.3% |
| RARX | Sell | RA PHARMACEUTICALS | $10,672,000 | -46.7% | 451,247 | -32.2% | 1.84% | -23.1% |
| COLL | Sell | COLLEGIUM PHARMACEUT | $10,392,000 | -32.7% | 905,247 | -22.9% | 1.79% | -2.9% |
| LJPC | Sell | LA JOLLA PHARMACLS | $10,193,000 | -33.5% | 1,158,271 | -30.1% | 1.76% | -4.1% |
| MRK | Sell | MERCK & CO INC | $9,900,000 | -29.2% | 117,600 | -29.5% | 1.71% | +2.2% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $9,557,000 | -27.1% | 141,801 | -7.4% | 1.65% | +5.2% |
| CI | Buy | CIGNA CORP | $9,474,000 | +27.1% | 62,413 | +31.9% | 1.63% | +83.4% |
| HRC | Sell | HILL-ROM HLDS INC | $9,271,000 | -44.2% | 88,099 | -44.5% | 1.60% | -19.5% |
| ZBH | Buy | ZIMMER BIOMET HLDS | $9,142,000 | +53.5% | 66,598 | +31.6% | 1.58% | +121.5% |
| BSX | Sell | BOSTON SCIENTIFIC | $9,040,000 | -7.2% | 222,176 | -1.9% | 1.56% | +34.0% |
| XLRN | Sell | ACCELERON PHARMA | $8,992,000 | -18.7% | 227,596 | -15.5% | 1.55% | +17.2% |
| RCM | Sell | R1 RCM INC | $8,837,000 | -34.9% | 989,572 | -8.3% | 1.52% | -6.0% |
| MDT | Sell | MEDTRONIC PLC | $7,891,000 | +5.4% | 72,651 | -5.5% | 1.36% | +52.1% |
| ABT | Buy | ABBOTT LABS | $7,296,000 | +4.3% | 87,198 | +4.8% | 1.26% | +50.4% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES | $7,077,000 | -38.1% | 719,896 | -15.1% | 1.22% | -10.7% |
| STML | Buy | STEMLINE THERAPEUT | $7,055,000 | -30.9% | 677,759 | +1.7% | 1.22% | -0.2% |
| TRHC | New | TABULA RASA HEALTH | $6,626,000 | – | 120,600 | +100.0% | 1.14% | – |
| PFE | Sell | PFIZER INC | $6,594,000 | -58.1% | 183,528 | -49.4% | 1.14% | -39.5% |
| SRPT | Sell | SAREPTA THERAPEUTICS | $6,357,000 | -64.3% | 84,398 | -27.9% | 1.10% | -48.4% |
| LLY | Sell | LILLY ELI & CO | $6,236,000 | -47.2% | 55,765 | -47.7% | 1.08% | -23.8% |
| OBSV | OBSEVA SA | $5,357,000 | -26.4% | 643,151 | 0.0% | 0.92% | +6.2% | |
| TMO | Buy | THERMO FISHER SCI | $5,301,000 | +423.3% | 18,200 | +427.5% | 0.92% | +656.2% |
| FTSV | Buy | FORTY SEVEN INC | $5,229,000 | -24.9% | 814,414 | +24.0% | 0.90% | +8.4% |
| CHNG | Sell | CHANGE HEALTHCARE IN | $4,901,000 | -25.5% | 405,750 | -9.9% | 0.85% | +7.5% |
| EVLO | Buy | EVELO BIOSCIENCES | $4,469,000 | -25.7% | 732,582 | +9.4% | 0.77% | +7.2% |
| VRAY | Buy | VIEWRAY INC | $3,599,000 | -61.9% | 1,240,865 | +15.8% | 0.62% | -45.0% |
| ALXN | Sell | ALEXION PHARM INC | $3,594,000 | -62.5% | 36,699 | -49.9% | 0.62% | -45.9% |
| MGTX | Sell | MEIRAGTX HLDINGS PLC | $3,275,000 | -46.1% | 205,306 | -9.1% | 0.56% | -22.2% |
| ALBO | Sell | ALBIREO PHARMA INC | $2,944,000 | -62.4% | 147,211 | -39.4% | 0.51% | -45.8% |
| HMSY | Sell | HMS HOLDINGS CORP | $2,679,000 | -73.4% | 77,725 | -75.0% | 0.46% | -61.7% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $2,401,000 | -65.3% | 14,171 | -62.5% | 0.41% | -50.0% |
| UMRX | Sell | UNUM THERAPEUTICS | $2,188,000 | -47.4% | 1,519,174 | -4.3% | 0.38% | -24.1% |
| MTEM | Sell | MOLECULAR TEMPLATES | $1,942,000 | -33.6% | 294,615 | -15.8% | 0.34% | -4.3% |
| SVRA | Sell | SAVARA INC | $1,882,000 | +7.2% | 710,310 | -4.2% | 0.32% | +54.8% |
| URGN | UROGEN PHARMA LTD | $1,550,000 | -33.7% | 65,063 | 0.0% | 0.27% | -4.6% | |
| RDY | DR REDDYS LABS LTDadr | $1,493,000 | +1.2% | 39,397 | 0.0% | 0.26% | +46.6% | |
| AGIO | Sell | AGIOS PHARMACEUTIC | $1,471,000 | -63.1% | 45,400 | -43.2% | 0.25% | -46.8% |
| SAGE | Sell | SAGE THERAPEUTICS | $1,473,000 | -67.0% | 10,500 | -57.0% | 0.25% | -52.4% |
| FIXX | New | HOMOLOGY MEDICINES | $1,346,000 | – | 74,381 | +100.0% | 0.23% | – |
| QURE | Buy | UNIQURE N.V. | $1,161,000 | +2.5% | 29,500 | +103.4% | 0.20% | +48.1% |
| SBPH | SPRING BK PHARMACE | $952,000 | -6.8% | 276,656 | 0.0% | 0.16% | +34.4% | |
| PHAS | Buy | PHASEBIO PHARMACEU | $817,000 | -64.6% | 196,000 | +11.4% | 0.14% | -48.9% |
| AGN | Sell | ALLERGAN PLC | $808,000 | -93.8% | 4,800 | -93.9% | 0.14% | -91.1% |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS | $0 | – | -39,821 | -100.0% | -0.00% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -41,076 | -100.0% | -0.00% | – |
| CLSD | Exit | CLEARSIDE BIOMEDICAL | $0 | – | -25,959 | -100.0% | -0.00% | – |
| CRVS | Exit | CORVUS PHARMACEUTICALS | $0 | – | -12,594 | -100.0% | -0.01% | – |
| ABEO | Exit | ABEONA THERAPEUTICS | $0 | – | -12,681 | -100.0% | -0.01% | – |
| BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -178,297 | -100.0% | -0.01% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS | $0 | – | -16,800 | -100.0% | -0.01% | – |
| Exit | NABRIVA THERAPEUTICS | $0 | – | -38,255 | -100.0% | -0.01% | – | |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS | $0 | – | -12,954 | -100.0% | -0.01% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -44,539 | -100.0% | -0.01% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS | $0 | – | -10,058 | -100.0% | -0.01% | – |
| RVNC | Exit | REVANCE THERAPEUTICS | $0 | – | -11,234 | -100.0% | -0.02% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS | $0 | – | -11,400 | -100.0% | -0.02% | – |
| ATRS | Exit | ANTARES PHARMA INC | $0 | – | -47,280 | -100.0% | -0.02% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -17,811 | -100.0% | -0.02% | – |
| ACRX | Exit | ACELRX PHARMACEUTICALS | $0 | – | -73,778 | -100.0% | -0.02% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -4,051 | -100.0% | -0.02% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -11,800 | -100.0% | -0.03% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS | $0 | – | -17,551 | -100.0% | -0.05% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -1,626 | -100.0% | -0.05% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -12,589 | -100.0% | -0.05% | – |
| HCM | Exit | HUTCHISON CHINA MEsponsored adr | $0 | – | -31,628 | -100.0% | -0.08% | – |
| BDX | Exit | BECTON DICKINSON | $0 | – | -3,015 | -100.0% | -0.09% | – |
| BPMC | Exit | BLUEPRINT MEDICINES | $0 | – | -10,984 | -100.0% | -0.12% | – |
| BGNE | Exit | BEIGENE LIMITEDsponsored adr | $0 | – | -11,227 | -100.0% | -0.17% | – |
| Exit | INTEC PHARMA LTD JER | $0 | – | -879,000 | -100.0% | -0.46% | – | |
| PODD | Exit | INSULET CORP | $0 | – | -36,160 | -100.0% | -0.52% | – |
| TOCA | Exit | TOCAGEN INC | $0 | – | -669,997 | -100.0% | -0.54% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -38,400 | -100.0% | -0.54% | – |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -552,806 | -100.0% | -0.79% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -794,868 | -100.0% | -4.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.